Look for:

Our offer for

WUXI BIOLOGICS (CAYMAN) INC.


ISIN:
KYG970081173
WKN:
-

2024/05/10 17:59:42
Price
1.8608 EUR
Difference 6.09% (0.11)

General attributes

ISINKYG970081173
Symbol2269
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,413 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.839 EUR (1,291)
Ask (Ask size)1.9012 EUR (1,241)
Open1.7624 EUR
High1.8608 EUR
Low1.7026 EUR
Close (prev. day)1.754 EUR
VWAP1.80896 EUR
Volume (pcs)15,542
Trading volume28,114.83
Number of trades17
Last size1,242

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/04/26 en Global Equity Ratings PDF Download
2024/04/03 en Global Equity Ratings PDF Download
2024/03/13 en Global Equity Ratings PDF Download
2024/02/22 en Global Equity Ratings PDF Download
2024/02/14 en Global Equity Ratings PDF Download


2024/05/10 17:59:42
Price
1.8608 EUR
Difference 6.09% (0.11)

General attributes

ISINKYG970081173
Symbol2269
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)7,413 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)1.839 EUR (1,291)
Ask (Ask size)1.9012 EUR (1,241)
Open1.7624 EUR
High1.8608 EUR
Low1.7026 EUR
Close (prev. day)1.754 EUR
VWAP1.80896 EUR
Volume (pcs)15,542
Trading volume28,114.83
Number of trades17
Last size1,242

Performance and Risk

6m1Y3Y
Perf (%)-70.91%-66.11%-84.20%
Perf (abs.)-4.28-3.42-9.35
Beta0.971.030.66
Volatility85.6271.4869.17
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.7204 EUR (3,654)
Ø price 30 days | Ø volume 30 days (pcs.)1.6510 EUR (6,545)
Ø price 100 days | Ø volume 100 days (pcs.)2.3242 EUR (10,914)
Ø price 250 days | Ø volume 250 days (pcs.)3.9876 EUR (6,257)
YTD High | date3.6720 EUR (2024/01/11)
YTD Low | date1.4930 EUR (2024/04/19)
52 Weeks High | date6.1900 EUR (2023/11/08)
52 Weeks Low | date1.4930 EUR (2024/04/19)

All listings for WUXI BIOLOGICS (CAYMAN) INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/05/1017:591.8608 EUR0.0317
Stuttgart2024/05/1011:051.7114 EUR0.002
Munich2024/05/1008:151.7168 EUR0.001
Hong Kong Stock Exchange2024/05/1010:0814.66 HKD--
Frankfurt2024/05/1016:201.8158 EUR0.014
FINRA other OTC Issues2024/05/1017:031.99 USD0.003
Duesseldorf2024/05/1019:301.8334 EUR0.005
Berlin2024/05/1018:461.8754 EUR0.006

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=143050&ID_TYPE_IMAGE_LOGO=2

Contact Details

WUXI BIOLOGICS (CAYMAN) INC.
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Members of Management Board

Zhisheng (Chris) Chen, Ph.D.Chairman of Managing Board
Christine Lu-WongMember of Executive Committee
Jijie Gu, Ph.D.Member of Executive Committee
Weichang Zhou, Ph.D.Member of Executive Committee

Board of directors

Ge LiChairman of Supervisory Board
Jue ChenMember of Supervisory Board
Weichang ZhouMember of Supervisory Board
Yi Bing WuMember of Supervisory Board
Jackson TaiMember of Supervisory Board
Kenneth HitchnerMember of Supervisory Board
William KellerMember of Supervisory Board
Yan Ling CaoMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer